SPEAKER Dr. Angelika Rambold Institute of Medical Biochemistry, ZMBE
Funded projects
He2/003/26 - AIMPs: Artificial Intelligence for Antimicrobial Peptides Principal investigator: Dominik Heider, Frieder Schaumburg Funding period: 01/2026 - 12/2028
Jo2/004/26 - Heterogeneity in Kupffer cell-mediated killing of Staphylococcus aureus in context of the microenvironment Principal investigator: Selina Kathleen Jorch Funding period: 01/2026 - 12/2028
Lud2/006/26 -Small spleenic peptides (SSP) as a novel antiinfective approach against hyperinflammatory respiratory virus diseases Principal investigator: Stephan Ludwig Funding period: 01/2026 - 12/2029
Soe2/007/26 - NeutroSense: Neutrophils as sensors of health and disease Principal investigator: Oliver Söhnlein Funding period: 01/2026 - 12/2028
Ram2/011/26 - OrgAIPlex: Functional morphometric organelle profiling of inflammatory cell responses Principal investigator: Angelika Rambold Funding period: 01/2026 - 12/2029
Ma2/012/26 - The role of alpha-actinin 1 in platelets for signalling, thrombus formation and thromboinflammation Principal investigator: Andreas Margraf Funding period: 01/2026 - 12/2028
Re2/014/26 - Weibel-Palade Body Dynamics and Endothelial Cell Adaptation Principal investigator: Ursula Rescher Funding period: 01/2026 - 12/2029
Nie2/018/26 - Investigating the Role of Thiol Isomerases in Staphylococcus aureus Uptake by Non-Professional Phagocytes Principal investigator: Silke Niemann Funding period: 01/2026 - 12/2029
Neu2/020/26 - Evaluating the immune cell impact as a contributor to male factor infertility Principal investigator: Nina Neuhaus, Sandra Laurentino Funding period: 01/2026 - 12/2028
Vo2/002/25 - Regulation of S100A8 and S100A9 expression in monocytes and neutrophils Principal investigator: Thomas Vogl Funding period: 01/2025 - 12/2027
Lae2/013/24 - The influence of mechnical stimuli on mast cell homeostasis and activation Principal investigator: Tim Lämmermann Funding period: 01/2024 - 12/2026
Om2/014/24 - Restoration of ciliary motility in respiratory cells from individuals with primary ciliary dyskinesia with defined aberrant splicing defects using anti-sense oligonucleotides Principal investigator: Heymut Omran Funding period: 01/2024 - 12/2026
Bru2/015/24 - Role of co-infecting bacteria and bacterial-derived outer membrane vesicles for the pathophysiology of viral pneumonia Principal investigators: Petra Dersch (until 10/25 Linda Brunotte) Funding period: 01/2024 - 12/2026
Bör2/023/24 - Deciphering the antibacterial action and targeting mechanisms of Zapnometinib against bacterial pathogens Principal investigator: Yvonne Börgeling Funding period: 01/2024 - 12/2026
Ross2/025/24 - The role of Myo9b in integrin activation and leukocyte recruitment Principal investigator: Jan Rossaint Funding period: 01/2024 - 12/2026
completed IZKF Projects - Scientific Focus Inflammation and Infection
Za2/002/23 - The role of alpha-actinin 1 in integrin activation and leukocyte recruitment Principal investigator: Alexander Zarbock Funding period: 01/2023 - 12/2025
SiRo2/009/23 - Hepatic neutrophil extracellular traps limit dissemination of gut-derived products Principal investigator: Carlos Silvestre Roig Funding period: 01/2023 - 12/2025
Erp2/016/23 - Neutrophil-derived dopamine as a modulator of inflammation Principal investigator: Luise Erpenbeck Funding period: 01/2023 - 12/2025
Wag2/032/23 - Tailoring immune responses during sepsis by DPP4 inhibition Principal investigator: Nana-Maria Wagner Funding period: 01/2023 - 12/2025 (Ended 12/2023)
Geo2/004/22 - Functional analysis of human disease mutations in the NPHS1 gene encoding the slit-diaphragm protein Nephrin Principal investigator: Britta George (since 11/23 Hermann Pavenstädt) Funding period: 01/2022 - 12/2024
Ro2/007/22 - Chromatin remodelling during tolerance induction in monocytes Principal investigator: Johannes Roth Funding period: 01/2022 - 12/2024
Dob2/010/22 - Unravelling the factors that shape the intracellular life cycle of uropathogenic E. coli Principal investigator: Ulrich Dobrindt Funding period: 01/2022 - 12/2024
Lue2/013/22 - AntibodyOMICs in autoimmune encephalitis Principal investigator: Jan Lünemann Funding period: 01/2022 - 07/2023
Wie2/014/22 - Role of CD8+ T cells in the pathophysiology of autoimmune encephalitis Principal investigator: Heinz Wiendl Funding period: 01/2022 - 12/2024
Me2/015/22 - Elucidation of factors and mechanisms leading to EHEC O104:H4 hyper-virulence during human infection Principal investigators: Alexander Mellmann, Petya Berger Funding period: 01/2022 - 12/2024
AlG2/026/22 - Novel roles of cellular cholesterol homeostasis in cell dynamics in monocytes Principal investigator: Noelia Alonso Gonzalez Funding period: 01/2022 - 12/2024
Str2/014/21 - The ligand-control of CatSper Ca2+ channels in human sperm Principal investigator: Timo Strünker Funding period: 01/2021 - 12/2023
Bör2/030/21 - Signalling networks in influenza virus assembly and budding - gateway for broad antiviral intervention against enveloped viruses? Principal investigator: Yvonne Börgeling Funding period: 01/2021 - 12/2022
Om2/010/20 - Molecular mechanisms involved in the regulation of the beta-dynein heavy chain in cilia and flagella Principal investigator: Heymut Omran Funding period: 01/2020 - 06/2023
Re2/022/20 - Dynamics of the Late Endosomal Host-Pathogen Interface in IAV Infection Principal investigator: Ursula Rescher Funding period: 01/2020 - 06/2023
De2/006/20 - Analysis of a protective role of coagulation activities and fibrin matrix formation against Yersinia infections Principal investigator: Petra Dersch Funding period: 01/2020 - 12/2022
Fö2/018/20 - The role of hexameric S100A12 complexes and type I interferon signals in promotingIL1/IL18-driven SJIA progression Principal investigator: Dirk Föll Funding period: 01/2020 - 12/2022
Vo2/011/19 - Restriction of autoimmunity in experimental mouse models of arthritis by myeloid-derived suppressor cells (MDSCs) Principal investigator: Thomas Vogl Funding period: 01/2019 - 06/2023
Brau2/013/19 - Impaired function of the nuclear pore complex as a novel pathogenic mechanism in kidney diseases Principal investigator: Daniela Braun Funding period: 01/2019 - 06/2022
Bru2/015/19 - Keeping the balance: Characterization of TRIM28 as a negative regulator of the pulmonary innate immune response during influenza A virus infection Principal investigator: Linda Brunotte Funding period: 01/2019 - 06/2022
Bäu2/009/19 - Creation of a novel antibody-drug conjugate for the treatment of diffuse large B-cell lymphoma Principal investigator: Sebastian Bäumer Funding period: 01/2019 - 12/2021
Ro2/023/19 - Molecular mechanisms of innate immune memory during activation of phagocytes Principal investigator: Johannes Roth Funding period: 01/2019 - 10/2021
Za2/001/18 - Novel functions of pulmonary endothelial and epithelial CXCR2 in leukocyte trafficking to infected lungs and in lung injury Principal investigator: Alexander Zarbock Funding period: 01/2018 - 10/2021
Ross2/010/18 - Renal tubular epithelial TLR4 signaling induces cell cycle arrest and attenuates acute kidney injury Principal investigator: Jan Rossaint Funding period: 01/2018 - 10/2021
Wed2/022/18 - Coordination and control of cell organization through the multifunctional actin regulator INF2 Principal investigator: Roland Wedlich-Söldner Funding period: 01/2018 - 10/2021
Fa2/014/18 - InfectionImaging – Development of a pathogen-specific diagnostic imaging marker for infective endocarditis Principal investigator: Cornelius Faber Funding period: 01/2018 - 12/2020
Schw2/020/18 - Mechanisms of mechanosignaling in pancreatic stellate cells and its role for pancreatic cancer Principal investigator: Albrecht Schwab Funding period: 01/2018 - 12/2020
Hei2/027/18 - Mechanisms involved in extracellular (e)DNA-dependent staphylococcal biofilm formation Principal investigator: Christine Heilmann Funding period: 01/2018 - 12/2020
Lud2/008/17 - Influenza Virus-mediated reprogramming of immunologically defective tumor-associated macrophages Principal investigator: Stephan Ludwig Funding period: 01/2017 - 10/2020
Drei2/018/17 - Deciphering bacterial communication under different environmental conditions at high spatio-temporal resolution by novel mass spectrometry imaging technologies Principal investigators: Klaus Dreisewerd, Jens Soltwisch Funding period: 01/2017 - 10/2020
Fau2/014/17 - Bacterial vascular graft infections - impact of sterile inflammation and tissue injury on biofilm formation and bacterially elicited processes Principal investigators: Andreas Faust, Silke Niemann Funding period: 1/2017 - 06/2020
Rüt2/002/16 - ‘CREDIBLE’: A Cre-mediated double reporter system to study cargo transport by delivery systems in vitro and in vivo Principal investigator: Christian Rüter Funding period: 01/2016 - 10/2019
Geo2/003/16 - Neurotrophic receptor kinase 3 (Ntrk3) in podocyte development and disease Principal investigator: Britta George Funding period: 01/2016 - 10/2019
Lo2/004/16 - Role of 4-1BB/4-1BB ligand signalling for the progression of cutaneous inflammation and the development of itch Principal investigator: Karin Loser Funding period: 01/2016 - 10/2019
Om2/015/16 - Molecular characterization of radial spoke composition and defects in Primary Ciliary Dyskinesia Principal investigator: Heymut Omran Funding period: 01/2016 - 10/2019
Kah2/016/16 - The interaction of Staphylococcus aureus with „neutrophil extracellular traps “ (NETs) during the chronic persistent airway infection of cystic fibrosis patients Principal investigator: Barbara Kahl Funding period: 01/2016 - 10/2019
Mat2/019/16 - Mechanobiological investigation of microtubules in tissue development and disease Principal investigator: Maja Matis Funding period: 01/2016 - 10/2019
Dob2/022/16 - Analysis of structural requirements and mechanisms involved in genome plasticity of Escherichia coli Principal investigator: Ulrich Dobrindt Funding period: 01/2016 - 10/2019
Me2/010/16 - EHEC-vesicles: their impact on host-pathogen interaction and gut flora Principal investigators: Alexander Mellmann, Helge Karch Funding period: 01/2016 - 12/2018
Ebl2/014/16 - Redox regulation of integrin-mediated cell-matrix contacts and its role in adhesion, cell morphology, and migration Principal investigator: Johannes Eble Funding period: 01/2016 - 12/2018
Raz2/021/16 - From cell migration to organ formation – Early interactions between somatic cells and migratory germ cells in early gonadogenesis Principal investigator: Erez Raz Funding period: 01/2016 - 12/2018
Ro2/003/15 - The role of calcium -binding proteins MRP8 and MRP14 during cellular dynamics in phagocytes Principal investigator: Johannes Roth Funding period: 01/2015 - 10/2018
EhC2/006/15 - Molecular mechanisms contributing to pathogenesis during influenza virus and Staphylococcus aureus co-infection Principal investigator: Christina Ehrhardt Funding period: 01/2015 - 10/2018
So2/016/15 - The role of Matrix Metalloproteinase (MMP)-2 and MMP-9 in initiating peripheral immune responses: impact on dendritic cell (dc) migration and antigen presentation Principal investigator: Lydia Sorokin Funding period: 01/2015 - 10/2018
Müth2/021/15 - Interaction of Shiga toxin with human intestinal and renal epithelial cells: therapy options for treatment of EHEC-mediated diseases Principal investigator: Johannes Müthing Funding period: 01/2015 - 10/2018
Ros2/007/15 - Role of the three-dimensional chromatin structure in expression control of the tumor suppressor gene PU.1 Principal investigator: Frank Rosenbauer Funding period: 01/2015 - 12/2017
Re2/026/15 - Impact of late endosomal cholesterol homeostasis on tetraspanin-based signalling Principal investigator: Ursula Rescher Funding period: 01/2015 - 12/2017
Har2/002/14 - Modified Wnt-signaling and its effects on degenerative and inflammatory joint alterations Principal investigator: Christine Hartmann Funding period: 01/2014 - 10/2017
Vo2/004/14 - The role of alarmins MRP8 and MRP14 in the differentiation of ‚Myeloid-Derived Suppressor Cells ‘ (MDSCs) in allergies and autoimmune diseases Principal investigator: Thomas Vogl Funding period: 01/2014 - 10/2017
Kl2/015/14 - Affinity-dependent modulation of T-cell responses- implications of DHODH and the de novo pyrimidine synthesis pathway Principal investigator: Luisa Klotz Funding period: 01/2014 - 10/2017
Eb2/020/14 - The signalling role of JAM-A during angiogenesis and tumorigenesis Principal investigator: Klaus Ebnet Funding period: 01/2014 - 10/2017
Hei2/027/14 - Characterization of the role of protein glycosylation in the Staphylococcus aureus pathogenesis Principal investigator: Christine Heilmann Funding period: 01/2014 - 10/2017
Za2/001/14 - The role of SKAP-HOM in integrin activation, leukocyte recruitment, and inflammation Principal investigator: Alexander Zarbock Funding period: 01/2014 - 12/2016
Ge2/009/14 - Plasma membrane wound repair in mechanically stressed cells Principal investigator: Volker Gerke Funding period: 1/2014 - 12/2016
Lud2/017/13 - Unraveling the phosphoproteom of influenza virus infected cells Principal investigator: Stephan Ludwig Funding period: 01/2013 - 10/2016
Cia2/013/13 - Membrane transporters as mediators of cisplatin effects and side effects Principal investigators: Giuliano Ciarimboli, Eberhard Schlatter, Antoinette am Zehnhoff-Dinnesen Funding period: 01/2013 - 09/2016
Schl2/001/13 - Germline stem cells and their niches: Is male infertility associated with defects of migration and colonization of spermatogonia? Principal investigator: Stefan Schlatt Funding period: 01/2013 -12/2015
SchMA2/014/13 - Application of bacterial immune regulatory cell -penetrating proteins in murine models of inflammatory bowel disease Principal investigator: M. Alexander Schmidt Funding period: 01/2013 -12/2015
Om2/009/12 - The role of cytoplasmic pre-assembly of axonemal components in primary ciliary dyskinesia Principal investigator: Heymut Omran Funding period: 01/2012 - 10/2015
Dob2/013/12 - Regulation of the biosynthesis of the enterobacterial genotoxin colibactin Principal investigator: Ulrich Dobrindt Funding period: 01/2012 - 10/2015
Pap2/015/12 - SUMO-1 as a modulator of inflammatory bone loss: Molecular mechanisms and therapeutic implications Principal investigator: Thomas Pap Funding period: 01/2012 - 10/2015
Me2/021/12 - Microevolution of enterohemorrhagic Escherichia coli (EHEC) O104:H4 and its impact on the pathogen-host interaction Principal investigators: Alexander Mellmann, Helge Karch Funding period: 01/2012 - 10/2015
Mei2/017/12 - Functions of CDKs in proliferation and inflammation Principal investigator: Michael Meisterernst Funding period:1/2012 - 12/2014
Lo2/004/11 - Relevance of OX40-OX40 ligand signalling for allergic and anti-microbial cutaneous immune responses Principal investigators: Karin Loser, Stefan Beissert Funding period: 01/2011-10/2014
Mül2/020/11 - The relevance of Histone 4 acetyltransferases in myeloid differentiation Principal investigator: Carsten Müller-Tidow Funding period: 01/2011 - 10/2014
Lud2/010/11 - Activation and function of the p38 MAP kinase pathway in influenza virus infected cells Principal investigator: Stephan Ludwig Funding period: 01/2011 - 12/2013
Eh2/019/11 - New anti-inflammatory mechanisms of glucocorticoids in vivo Principal investigators: Jan Ehrchen, Cord Sunderkötter Funding period:1/2011 - 12/2013
Be2/023/11 - Pathogenicity of Staphylococcus lugdunensis Principal investigator: Karsten Becker Funding period: 01/2011 - 12/2013
Ro2/004/10 - Characterisation of the molecular mechanisms of LPS- or stress-induced microbial tolerance in phagocytes Principal investigator: Johannes Roth Funding period:1/2010-10/2013
Ge2/016/10 - Ca2+-dependent regulation of membrane/cytoskeleton interactions in migratory leukocytes and tumour cells Principal investigator: Volker Gerke Funding period: 01/2010 -10/2013
Re2/017/10 - Annexin A8 and the pathophysiology of tumours Principal investigator: Ursula Rescher Funding period: 01/2010 -10/2013
Müth2/028/10 - Interaction of glycosphingolipids from human cells with virulence factors of entero-hemorrhagic Escherichia coli (EHEC) Principal investigator: Johannes Müthing Funding period: 01/2010 -10/2013
Löf2/030/10 - Mechanisms of intracellular persistence of Staphylococcus aureus via formation of highly dynamic phenotypes Principal investigators: Bettina Löffler, Georg Peters Funding period: 01/2010 -10/2013
Za2/001/10 - The role of phopholipase C gamma (PLCγ) isoforms in selectin-mediated leukocyte activation Principal investigator: Alexander Zarbock Funding period: 01/2010-12/2012
Wix2/005/10 - The LIM-domain protein FHL2 as a novel regulator of innate cellular anti-viral response Principal investigators: Viktor Wixler, Christina Ehrhardt Funding period: 01/2010-12/2012
Goe2/023/10 - Role of platelet adhesion receptors for the acute and chronic inflammation of the skin Principal investigator: Tobias Görge Funding period: 01/2010-12/2012
Vo2/014/09 - Novel strategies in sepsis therapy – characterization of pro-inflammatory mechanisms of human MRP8 and MRP14 Principal investigator: Thomas Vogl Funding period: 01/2009 - 10/2012
Hei2/022/09 - Molecular characterization of the SasC -mediated mechanism of cell aggregation and biofilm formation in Staphylococcus aureus Principal investigator: Christine Heilmann Funding period: 01/2009 - 10/2012
Kah2/024/09 - In vivo evolution of Staphylococcus aureus during chronic airway infection of cystic fibrosis patients Principal investigator: Barbara Kahl Funding period: 01/2009 - 10/2012
Schä2/020/09 - Molecular imaging of activated matrix metalloproteinases in encephalomyelitis Principal investigators: Michael Schäfers, Klaus Kopka, Lydia Sorokin Funding period: 01/2009 - 12/2011
Eb2/028/09 - Regulation of membrane polarity in endothelial cells by the VE-cadherin - Par protein complex Principal investigator: Klaus Ebnet Funding period: 01/2009 - 12/2011
Me2/023/08 - Mobility and dynamic of pathogenicity determinants of enterohaemorrhagic Escherichia coli (EHEC) during infection Principal investigators: Alexander Mellmann, Helge Karch Funding period: 01/2008 - 10/2011
SchMA2/027/08 - Probiotic Bacteria and the Gastrointestinal Barrier: target Structures and Molecular Repair Mechanisms Principal investigator: M. Alexander Schmidt Funding period: 01/2008 - 10/2011
Schw2/030/08 - Calcium channels as mechanosensors in migrating cells Principal investigator: Albrecht Schwab Funding period: 01/2008 - 10/2011
Mül2/018/07 - Combinatorial gene regulation as a prerequisite for cellular dynamics in hematopoietic differentiation Principal investigator: Carsten Müller-Tidow Funding period: 01/2007 -10/2010
Sun2/017/07 - Influence of initial epidermal cytokine expression on the adaptive immune response in experimental Leishmaniasis Principal investigators: Cord Sunderkötter, Jan Ehrchen Funding period: 01/2007 -10/2010
Pap2/003/07 - Regulation of apoptosis in rheumatoid arthritis syvnovial fibroblasts by the tissue inhibitor of metalloproteinases (TIMP-3) Principal investigator: Thomas Pap Funding period: 1/2007 - 12/2009
Lo2/017/07 - Relevance of cutaneous RANK-RANKL signalling in immunity Principal investigator: Karin Loser Funding period: 01/2007 - 12/2009
Wi2/023/07 - Potential of spermatogonial stem cells for cellular renewal in testis and bone marrow Principal investigators: Joachim Wistuba, Steffen Koschmieder, Jörg Gromoll Funding period: 01/2007 - 12/2009
Re2/039/07 - Annexin 2 and raft domains and their associated proteins in cellular motility Principal investigator: Ursula Rescher Funding period: 01/2007 - 12/2009
Fö2/005/06 - Molecular characterisation of RAGE-mediated endothelial activation Principal investigators: Dirk Föll, Dorothee Viemann Funding period: 01/2006 - 10/2009
Ro2/012/06 - Anti-inflammatory mechanisms of macrophages Principal investigator: Johannes Roth Funding period: 01/2006 - 10/2009
Ge2/017/06 - Regulation of the acute secretion of inflammatory and thrombogenic factors from vascular endothelial cells Principal investigator: Volker Gerke Funding period:1/2006 - 10/2009
Lud2/032/06 - Molecular basis of the oncolytic activity of RNA viruses Principal investigator: Stephan Ludwig Funding period: 01/2006 - 10/2009
Si2/039/06 - Mechanisms of induction of apoptosis by Staphylococcus aureus in leukocytes and endothelial cells Principal investigators: Bhanu Sinha, Bettina Löffler Funding period: 01/2006 - 10/2009
Kuc2/018/06 - The deletion of CCR6 inhibits Peyer’s patches and isolated lymphoid follicles – implications of the organized GALT for the intestinal immune system Principal investigators: Torsten Kucharzik, Andreas Lügering Funding period: 01/2006 - 12/2008
Schae2/026/06 - Macrophage-colony stimulating factor isoforms: relevance and regulation in Lupus nephritis Principal investigators: Liliana Schaefer, Roland M. Schaefer, Peter Bruckner Funding period: 01/2006 - 12/2008
Stei2/017/06 Molecular and functional investigations on the role of endopeptidases for the regulation of neuropeptide receptor signalling Principal investigators: Martin Steinhoff, Thomas Luger Funding period: 01/2006 - 12/2008
Ser2/038/06 - JAK-STAT signal transduction in leukemic transformation – role of SOCS1 as a conditional oncogene Principal investigators: Hubert Serve, Christian Brandts Funding period: 01/2006 - 12/2008
Vest2/006/04 - Role of CD99 in transendothelial migration and extravasation of leukocytes Principal investigator: Dietmar Vestweber Funding period: 06/2004 - 12/2006
Na2/009/04 - Analyis of the S100 protein associated proteome in inflammation Principal investigator: Wolfgang Nacken Funding period: 06/2004 - 12/2006
Kess2/023/04 - Hematopoetic stem cells as targets for antivascular treatment strategies in cancer Principal investigators: Torsten Kessler, Rolf Mesters Funding period: 06/2004 - 12/2006
Hei2/042/04 - Molecular characterisation of adhesive interactions between Staphylococcus aureus and candida Principal investigators: Christine Heilmann, Chrsitof von Eiff, Karsten Becker Funding period: 06/2004 - 12/2006
Ka2/061/04 - Pathomechanisms of the interaction between enterohaemorrhagic Escherichia coli and intestinal epithelial cells Principal investigators: Helge Karch, Alexander W. Friedrich Funding period: 06/2004 - 12/2006
Lo2/065/04 - Investigations on the role of interleukin (IL)-15 for linking adaptive and innate cutaneous immunity Principal investigator: Karin Loser Funding period: 06/2004 - 12/2006
Mül2/096/04 - The role of the Cyclin A1 interacting protein (FOCA1 – Friend of Cyclin A1) for cell cycle progression and proliferation of haematopoietic cells Principal investigator: Carsten Müller-Tidow Funding period: 06/2004 - 12/2006
Pa2/108/04 - The role of C/EBP-homologous protein (CHOP) in oxygen-radical mediated damage of podocytes Principal investigator: Hermann-Joseph Pavenstädt Funding period:0 6/2004 - 12/2006
Ra2/109/04 - New therapeutic strategies for implant associated infections in surgery of the musculoskeletal system Principal investigator: Michael Raschke Funding period:0 6/2004 - 12/2006
Fö2/026/04 - Functional characterisation of calium-binding protein S100A12 specifically expressed in granulocytes Principal investigators: Dirk Föll, Johannes Roth Funding period:0 6/2004 - 12/2005
Re2/033/04 - Functional characterisation of calium-binding protein S100A12 specifically expressed in granulocytes Principal investigators: Ursula Rescher, Volker Gerke Funding period: 06/2004 - 12/2005
Si2/048/04 - Analysis of structure and function of Staphylococcus aureus-FnBPin invasion of human host cells Principal investigators: Bhanu Sinha, Christine Heilmann, Georg Peters Funding period: 06/2004 - 12/2005
Schae2/004/04 - Pathogenic role of proteolycans in the development of glomerulosclerosis and obstructive neuropathy Principal investigators: Roland M. Schaefer, Liliana Schaefer, Frank G. Echtermeyer Funding period: 06/2004 - 12/2005
Ser2/041/04 - Functional relevance of Flt-3 target genes in haematopoesis Principal investigators: Hubert Serve, Christian Barndts Funding period: 06/2004 - 12/2005
Stei2/103/04 - Molecular mechanisms of cutaneous neurogenic inflammation Principal investigators: Martin Steinhoff, Thomas Luger Funding period:0 6/2004 - 12/2005
Schl2/008/04 - Pathophysiology and cellular mechanisms of tubular transport differences after kidney transplantation Principal investigators: Eberhard Schlatter, Gerd Gabriels Funding period: 06/2004 - 12/2004
Kul2/016/04 - Molecular mechanisms of UV-induced apoptosis Principal investigators: Dagmar Kulms, Thomas Schwarz Funding period: 06/2004 - 12/2004